International Courant
Former pharmaceutical firm govt Martin Shkreli and his lead lawyer Benjamin Brafman arrive on the US District Courtroom for the fourth day of jury deliberation in his securities fraud trial within the Brooklyn borough of New York Metropolis, US, August 3, 2017.
Amr Alfiky | Reuters
The Supreme Courtroom on Monday rejected a bid by notorious “pharma bro” Martin Shkreli to listen to his enchantment towards a $64 million monetary penalty imposed on the fraudster for blocking competitors from a life-saving drug he priced by greater than $700 a month. capsule had elevated.
Shkreli’s request for the Supreme Courtroom to listen to his enchantment of the federal courtroom determination was his final probability to overturn that sentence, which was associated to the drug Daraprim.
That is the newest information. Refresh the web page for updates.
